GB2247238A - Alpha-glucosidase gene from Candida tsukubaensis cloned and expressed in Saccharomyces cerevisiae - Google Patents
Alpha-glucosidase gene from Candida tsukubaensis cloned and expressed in Saccharomyces cerevisiae Download PDFInfo
- Publication number
- GB2247238A GB2247238A GB9018268A GB9018268A GB2247238A GB 2247238 A GB2247238 A GB 2247238A GB 9018268 A GB9018268 A GB 9018268A GB 9018268 A GB9018268 A GB 9018268A GB 2247238 A GB2247238 A GB 2247238A
- Authority
- GB
- United Kingdom
- Prior art keywords
- cerevisiae
- alpha
- gene
- fragment
- dna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 240000004808 Saccharomyces cerevisiae Species 0.000 title claims abstract description 49
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 title claims abstract description 49
- 241000222180 Pseudozyma tsukubaensis Species 0.000 title claims abstract description 35
- 108010028144 alpha-Glucosidases Proteins 0.000 title abstract description 3
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 68
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 9
- 239000000463 material Substances 0.000 claims abstract description 5
- 239000012634 fragment Substances 0.000 claims description 59
- 230000000694 effects Effects 0.000 claims description 54
- 239000002773 nucleotide Substances 0.000 claims description 21
- 125000003729 nucleotide group Chemical group 0.000 claims description 21
- 238000000034 method Methods 0.000 claims description 16
- 239000007864 aqueous solution Substances 0.000 claims description 2
- 239000007900 aqueous suspension Substances 0.000 claims description 2
- 239000006185 dispersion Substances 0.000 claims description 2
- 230000001131 transforming effect Effects 0.000 claims description 2
- 102000004190 Enzymes Human genes 0.000 abstract description 50
- 108090000790 Enzymes Proteins 0.000 abstract description 50
- 239000013612 plasmid Substances 0.000 abstract description 45
- 230000003625 amylolytic effect Effects 0.000 abstract description 17
- 235000013405 beer Nutrition 0.000 abstract description 10
- 238000004519 manufacturing process Methods 0.000 abstract description 8
- 102100024295 Maltase-glucoamylase Human genes 0.000 abstract 1
- 229940088598 enzyme Drugs 0.000 description 47
- 108020004414 DNA Proteins 0.000 description 35
- 102000053602 DNA Human genes 0.000 description 35
- HNDVDQJCIGZPNO-UHFFFAOYSA-N Histidine Chemical compound OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 34
- 229920001353 Dextrin Polymers 0.000 description 31
- 239000004375 Dextrin Substances 0.000 description 31
- 235000019425 dextrin Nutrition 0.000 description 31
- 239000002609 medium Substances 0.000 description 22
- 239000000758 substrate Substances 0.000 description 22
- 101100387135 Caenorhabditis elegans dex-1 gene Proteins 0.000 description 20
- 108090000765 processed proteins & peptides Proteins 0.000 description 20
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 18
- 210000004027 cell Anatomy 0.000 description 18
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 17
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 17
- 101000666833 Autographa californica nuclear polyhedrosis virus Uncharacterized 20.8 kDa protein in FGF-VUBI intergenic region Proteins 0.000 description 15
- 101000977027 Azospirillum brasilense Uncharacterized protein in nodG 5'region Proteins 0.000 description 15
- 101000962005 Bacillus thuringiensis Uncharacterized 23.6 kDa protein Proteins 0.000 description 15
- 101000785191 Drosophila melanogaster Uncharacterized 50 kDa protein in type I retrotransposable element R1DM Proteins 0.000 description 15
- 101000747704 Enterobacteria phage N4 Uncharacterized protein Gp1 Proteins 0.000 description 15
- 101000861206 Enterococcus faecalis (strain ATCC 700802 / V583) Uncharacterized protein EF_A0048 Proteins 0.000 description 15
- 101000769180 Escherichia coli Uncharacterized 11.1 kDa protein Proteins 0.000 description 15
- 101000976301 Leptospira interrogans Uncharacterized 35 kDa protein in sph 3'region Proteins 0.000 description 15
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 15
- 101000658690 Neisseria meningitidis serogroup B Transposase for insertion sequence element IS1106 Proteins 0.000 description 15
- 101000748660 Pseudomonas savastanoi Uncharacterized 21 kDa protein in iaaL 5'region Proteins 0.000 description 15
- 101000584469 Rice tungro bacilliform virus (isolate Philippines) Protein P1 Proteins 0.000 description 15
- 101000818096 Spirochaeta aurantia Uncharacterized 15.5 kDa protein in trpE 3'region Proteins 0.000 description 15
- 101000766081 Streptomyces ambofaciens Uncharacterized HTH-type transcriptional regulator in unstable DNA locus Proteins 0.000 description 15
- 101000804403 Synechococcus elongatus (strain PCC 7942 / FACHB-805) Uncharacterized HIT-like protein Synpcc7942_1390 Proteins 0.000 description 15
- 101000750910 Synechococcus elongatus (strain PCC 7942 / FACHB-805) Uncharacterized HTH-type transcriptional regulator Synpcc7942_2319 Proteins 0.000 description 15
- 101000644897 Synechococcus sp. (strain ATCC 27264 / PCC 7002 / PR-6) Uncharacterized protein SYNPCC7002_B0001 Proteins 0.000 description 15
- 101000916336 Xenopus laevis Transposon TX1 uncharacterized 82 kDa protein Proteins 0.000 description 15
- 101001000760 Zea mays Putative Pol polyprotein from transposon element Bs1 Proteins 0.000 description 15
- 101000678262 Zymomonas mobilis subsp. mobilis (strain ATCC 10988 / DSM 424 / LMG 404 / NCIMB 8938 / NRRL B-806 / ZM1) 65 kDa protein Proteins 0.000 description 15
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 14
- 229920002472 Starch Polymers 0.000 description 14
- 239000012228 culture supernatant Substances 0.000 description 14
- 235000019698 starch Nutrition 0.000 description 14
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 13
- 108091008146 restriction endonucleases Proteins 0.000 description 13
- 239000008107 starch Substances 0.000 description 13
- 102000004169 proteins and genes Human genes 0.000 description 12
- 239000013598 vector Substances 0.000 description 12
- 241000588724 Escherichia coli Species 0.000 description 11
- 239000008103 glucose Substances 0.000 description 11
- 229920000642 polymer Polymers 0.000 description 11
- 150000001413 amino acids Chemical class 0.000 description 10
- 239000013611 chromosomal DNA Substances 0.000 description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- 238000010367 cloning Methods 0.000 description 8
- 102000004196 processed proteins & peptides Human genes 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 108091028043 Nucleic acid sequence Proteins 0.000 description 7
- 244000206963 Saccharomyces cerevisiae var. diastaticus Species 0.000 description 7
- 125000000539 amino acid group Chemical group 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 239000011780 sodium chloride Substances 0.000 description 7
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 6
- OBMZMSLWNNWEJA-XNCRXQDQSA-N C1=CC=2C(C[C@@H]3NC(=O)[C@@H](NC(=O)[C@H](NC(=O)N(CC#CCN(CCCC[C@H](NC(=O)[C@@H](CC4=CC=CC=C4)NC3=O)C(=O)N)CC=C)NC(=O)[C@@H](N)C)CC3=CNC4=C3C=CC=C4)C)=CNC=2C=C1 Chemical compound C1=CC=2C(C[C@@H]3NC(=O)[C@@H](NC(=O)[C@H](NC(=O)N(CC#CCN(CCCC[C@H](NC(=O)[C@@H](CC4=CC=CC=C4)NC3=O)C(=O)N)CC=C)NC(=O)[C@@H](N)C)CC3=CNC4=C3C=CC=C4)C)=CNC=2C=C1 OBMZMSLWNNWEJA-XNCRXQDQSA-N 0.000 description 6
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 6
- 101710176384 Peptide 1 Proteins 0.000 description 6
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 239000000872 buffer Substances 0.000 description 6
- 235000014633 carbohydrates Nutrition 0.000 description 6
- 229960001484 edetic acid Drugs 0.000 description 6
- 238000011534 incubation Methods 0.000 description 6
- 229920001184 polypeptide Polymers 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- 210000005253 yeast cell Anatomy 0.000 description 6
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 108010056771 Glucosidases Proteins 0.000 description 5
- 125000003275 alpha amino acid group Chemical group 0.000 description 5
- 229910052799 carbon Inorganic materials 0.000 description 5
- 238000012790 confirmation Methods 0.000 description 5
- 238000009396 hybridization Methods 0.000 description 5
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 5
- 239000002243 precursor Substances 0.000 description 5
- 230000000717 retained effect Effects 0.000 description 5
- 235000000346 sugar Nutrition 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 101000977023 Azospirillum brasilense Uncharacterized 17.8 kDa protein in nodG 5'region Proteins 0.000 description 4
- 101000961984 Bacillus thuringiensis Uncharacterized 30.3 kDa protein Proteins 0.000 description 4
- 108091026890 Coding region Proteins 0.000 description 4
- 101000644901 Drosophila melanogaster Putative 115 kDa protein in type-1 retrotransposable element R1DM Proteins 0.000 description 4
- 101000747702 Enterobacteria phage N4 Uncharacterized protein Gp2 Proteins 0.000 description 4
- 101000758599 Escherichia coli Uncharacterized 14.7 kDa protein Proteins 0.000 description 4
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 4
- 101000768930 Lactococcus lactis subsp. cremoris Uncharacterized protein in pepC 5'region Proteins 0.000 description 4
- 101000976302 Leptospira interrogans Uncharacterized protein in sph 3'region Proteins 0.000 description 4
- 101000778886 Leptospira interrogans serogroup Icterohaemorrhagiae serovar Lai (strain 56601) Uncharacterized protein LA_2151 Proteins 0.000 description 4
- 108010076504 Protein Sorting Signals Proteins 0.000 description 4
- 101001121571 Rice tungro bacilliform virus (isolate Philippines) Protein P2 Proteins 0.000 description 4
- 101000818098 Spirochaeta aurantia Uncharacterized protein in trpE 3'region Proteins 0.000 description 4
- 101001026590 Streptomyces cinnamonensis Putative polyketide beta-ketoacyl synthase 2 Proteins 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- 101000750896 Synechococcus elongatus (strain PCC 7942 / FACHB-805) Uncharacterized protein Synpcc7942_2318 Proteins 0.000 description 4
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 4
- 239000006035 Tryptophane Substances 0.000 description 4
- 101000916321 Xenopus laevis Transposon TX1 uncharacterized 149 kDa protein Proteins 0.000 description 4
- 101000760088 Zymomonas mobilis subsp. mobilis (strain ATCC 10988 / DSM 424 / LMG 404 / NCIMB 8938 / NRRL B-806 / ZM1) 20.9 kDa protein Proteins 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 238000000855 fermentation Methods 0.000 description 4
- 230000004151 fermentation Effects 0.000 description 4
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 4
- 101150066555 lacZ gene Proteins 0.000 description 4
- 102000039446 nucleic acids Human genes 0.000 description 4
- 108020004707 nucleic acids Proteins 0.000 description 4
- 150000007523 nucleic acids Chemical class 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- 229960004799 tryptophan Drugs 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 241000228245 Aspergillus niger Species 0.000 description 3
- 102000004366 Glucosidases Human genes 0.000 description 3
- 239000004677 Nylon Substances 0.000 description 3
- 108020004511 Recombinant DNA Proteins 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 102000005936 beta-Galactosidase Human genes 0.000 description 3
- 108010005774 beta-Galactosidase Proteins 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 229920001778 nylon Polymers 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 229910001868 water Inorganic materials 0.000 description 3
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 description 3
- 101150028074 2 gene Proteins 0.000 description 2
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 description 2
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 2
- 241001513093 Aspergillus awamori Species 0.000 description 2
- 241000222122 Candida albicans Species 0.000 description 2
- 108020004705 Codon Proteins 0.000 description 2
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 description 2
- QWIZNVHXZXRPDR-UHFFFAOYSA-N D-melezitose Natural products O1C(CO)C(O)C(O)C(O)C1OC1C(O)C(CO)OC1(CO)OC1OC(CO)C(O)C(O)C1O QWIZNVHXZXRPDR-UHFFFAOYSA-N 0.000 description 2
- ZCLAHGAZPPEVDX-UHFFFAOYSA-N D-panose Natural products OC1C(O)C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC1COC1C(O)C(O)C(O)C(CO)O1 ZCLAHGAZPPEVDX-UHFFFAOYSA-N 0.000 description 2
- 102000012410 DNA Ligases Human genes 0.000 description 2
- 108010061982 DNA Ligases Proteins 0.000 description 2
- 241001524679 Escherichia virus M13 Species 0.000 description 2
- 101000833492 Homo sapiens Jouberin Proteins 0.000 description 2
- 101000651236 Homo sapiens NCK-interacting protein with SH3 domain Proteins 0.000 description 2
- AYRXSINWFIIFAE-SCLMCMATSA-N Isomaltose Natural products OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@@H](O)[C@@H](O)[C@@H]1O AYRXSINWFIIFAE-SCLMCMATSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 102100024407 Jouberin Human genes 0.000 description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- 108700026244 Open Reading Frames Proteins 0.000 description 2
- 101710159752 Poly(3-hydroxyalkanoate) polymerase subunit PhaE Proteins 0.000 description 2
- 101710130262 Probable Vpr-like protein Proteins 0.000 description 2
- 239000004373 Pullulan Substances 0.000 description 2
- 229920001218 Pullulan Polymers 0.000 description 2
- 102000006382 Ribonucleases Human genes 0.000 description 2
- 108010083644 Ribonucleases Proteins 0.000 description 2
- 101000895926 Streptomyces plicatus Endo-beta-N-acetylglucosaminidase H Proteins 0.000 description 2
- 102400000472 Sucrase Human genes 0.000 description 2
- 108010040715 Sucrase-Isomaltase Complex Proteins 0.000 description 2
- DRQXUCVJDCRJDB-UHFFFAOYSA-N Turanose Natural products OC1C(CO)OC(O)(CO)C1OC1C(O)C(O)C(O)C(CO)O1 DRQXUCVJDCRJDB-UHFFFAOYSA-N 0.000 description 2
- LUEWUZLMQUOBSB-UHFFFAOYSA-N UNPD55895 Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(OC3C(OC(O)C(O)C3O)CO)C(O)C2O)CO)C(O)C1O LUEWUZLMQUOBSB-UHFFFAOYSA-N 0.000 description 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- LUEWUZLMQUOBSB-ZLBHSGTGSA-N alpha-maltotetraose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](O[C@H](O[C@@H]3[C@H](O[C@H](O)[C@H](O)[C@H]3O)CO)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-ZLBHSGTGSA-N 0.000 description 2
- 239000012223 aqueous fraction Substances 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 230000000593 degrading effect Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- 235000011073 invertase Nutrition 0.000 description 2
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- UYQJCPNSAVWAFU-UHFFFAOYSA-N malto-tetraose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(O)C(CO)O2)O)C(CO)O1 UYQJCPNSAVWAFU-UHFFFAOYSA-N 0.000 description 2
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 description 2
- 238000013507 mapping Methods 0.000 description 2
- QWIZNVHXZXRPDR-WSCXOGSTSA-N melezitose Chemical compound O([C@@]1(O[C@@H]([C@H]([C@@H]1O[C@@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O)CO)CO)[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O QWIZNVHXZXRPDR-WSCXOGSTSA-N 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- ZCLAHGAZPPEVDX-MQHGYYCBSA-N panose Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@@H](O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O)O[C@@H]1CO[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 ZCLAHGAZPPEVDX-MQHGYYCBSA-N 0.000 description 2
- 238000009928 pasteurization Methods 0.000 description 2
- 238000007747 plating Methods 0.000 description 2
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000011533 pre-incubation Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000002797 proteolythic effect Effects 0.000 description 2
- 235000019423 pullulan Nutrition 0.000 description 2
- FGDZQCVHDSGLHJ-UHFFFAOYSA-M rubidium chloride Chemical compound [Cl-].[Rb+] FGDZQCVHDSGLHJ-UHFFFAOYSA-M 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 230000014621 translational initiation Effects 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- RULSWEULPANCDV-PIXUTMIVSA-N turanose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](C(=O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RULSWEULPANCDV-PIXUTMIVSA-N 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- OVGWMUWIRHGGJP-WVDJAODQSA-N (z)-7-[(1s,3r,4r,5s)-3-[(e,3r)-3-hydroxyoct-1-enyl]-6-thiabicyclo[3.1.1]heptan-4-yl]hept-5-enoic acid Chemical compound OC(=O)CCC\C=C/C[C@@H]1[C@@H](/C=C/[C@H](O)CCCCC)C[C@@H]2S[C@H]1C2 OVGWMUWIRHGGJP-WVDJAODQSA-N 0.000 description 1
- GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 1
- YKBGVTZYEHREMT-KVQBGUIXSA-N 2'-deoxyguanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](CO)O1 YKBGVTZYEHREMT-KVQBGUIXSA-N 0.000 description 1
- OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 102000013563 Acid Phosphatase Human genes 0.000 description 1
- 108010051457 Acid Phosphatase Proteins 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 229920000945 Amylopectin Polymers 0.000 description 1
- 229920000856 Amylose Polymers 0.000 description 1
- 101100387134 Arabidopsis thaliana DEX1 gene Proteins 0.000 description 1
- 206010007134 Candida infections Diseases 0.000 description 1
- 241000222178 Candida tropicalis Species 0.000 description 1
- 108700010070 Codon Usage Proteins 0.000 description 1
- 241000235646 Cyberlindnera jadinii Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 102000004594 DNA Polymerase I Human genes 0.000 description 1
- 108010017826 DNA Polymerase I Proteins 0.000 description 1
- 108020003215 DNA Probes Proteins 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 238000007399 DNA isolation Methods 0.000 description 1
- 239000003298 DNA probe Substances 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 108010053770 Deoxyribonucleases Proteins 0.000 description 1
- 102000016911 Deoxyribonucleases Human genes 0.000 description 1
- 238000009007 Diagnostic Kit Methods 0.000 description 1
- 101000988961 Escherichia coli Heat-stable enterotoxin A2 Proteins 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- 108700007698 Genetic Terminator Regions Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 108091092195 Intron Proteins 0.000 description 1
- 102400000471 Isomaltase Human genes 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- LSPYFSHXDAYVDI-SRVKXCTJSA-N Leu-Ala-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC(C)C LSPYFSHXDAYVDI-SRVKXCTJSA-N 0.000 description 1
- 108010026867 Oligo-1,6-Glucosidase Proteins 0.000 description 1
- 108010055012 Orotidine-5'-phosphate decarboxylase Proteins 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 238000013494 PH determination Methods 0.000 description 1
- 101150012394 PHO5 gene Proteins 0.000 description 1
- 101150013176 POF1 gene Proteins 0.000 description 1
- 108020002230 Pancreatic Ribonuclease Proteins 0.000 description 1
- 102000005891 Pancreatic ribonuclease Human genes 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 102100026123 Pirin Human genes 0.000 description 1
- 101710184309 Probable sucrose-6-phosphate hydrolase Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 241000303962 Rhizopus delemar Species 0.000 description 1
- 241000952054 Rhizopus sp. Species 0.000 description 1
- 101100434411 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) ADH1 gene Proteins 0.000 description 1
- 101100408802 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) POF1 gene Proteins 0.000 description 1
- 101100216055 Saccharomyces cerevisiae STA2 gene Proteins 0.000 description 1
- 235000001006 Saccharomyces cerevisiae var diastaticus Nutrition 0.000 description 1
- 241000235004 Saccharomycopsis fibuligera Species 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 101710112652 Sucrose-6-phosphate hydrolase Proteins 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 239000007984 Tris EDTA buffer Substances 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 101150102866 adc1 gene Proteins 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 102000016679 alpha-Glucosidases Human genes 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000000376 autoradiography Methods 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 201000003984 candidiasis Diseases 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000007398 colorimetric assay Methods 0.000 description 1
- 229940116283 combination glucose Drugs 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000027832 depurination Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 108010030074 endodeoxyribonuclease MluI Proteins 0.000 description 1
- 238000003028 enzyme activity measurement method Methods 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000012239 gene modification Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 230000005017 genetic modification Effects 0.000 description 1
- 235000013617 genetically modified food Nutrition 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 125000001475 halogen functional group Chemical group 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 239000001573 invertase Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- XIXADJRWDQXREU-UHFFFAOYSA-M lithium acetate Chemical compound [Li+].CC([O-])=O XIXADJRWDQXREU-UHFFFAOYSA-M 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 150000002692 maltoses Chemical class 0.000 description 1
- 238000005360 mashing Methods 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 230000012666 negative regulation of transcription by glucose Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 235000020030 perry Nutrition 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- -1 phenyl- Chemical group 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000001323 posttranslational effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000000734 protein sequencing Methods 0.000 description 1
- 210000001938 protoplast Anatomy 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000011451 sequencing strategy Methods 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 239000013605 shuttle vector Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 238000012289 standard assay Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- DKVBOUDTNWVDEP-NJCHZNEYSA-N teicoplanin aglycone Chemical compound N([C@H](C(N[C@@H](C1=CC(O)=CC(O)=C1C=1C(O)=CC=C2C=1)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)OC=1C=C3C=C(C=1O)OC1=CC=C(C=C1Cl)C[C@H](C(=O)N1)NC([C@H](N)C=4C=C(O5)C(O)=CC=4)=O)C(=O)[C@@H]2NC(=O)[C@@H]3NC(=O)[C@@H]1C1=CC5=CC(O)=C1 DKVBOUDTNWVDEP-NJCHZNEYSA-N 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 230000005026 transcription initiation Effects 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
- 239000007966 viscous suspension Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
- C12N9/2411—Amylases
- C12N9/2428—Glucan 1,4-alpha-glucosidase (3.2.1.3), i.e. glucoamylase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
A gene (Figure 5) encoding an amylolytic enzyme (alpha-glucosidase) from Candida tsukubaensis has been cloned, sequenced, and expressed in Saccharomyces cerevisiae. The cloned material is present on the plasmid pGA8701 (which has been deposited as S. cerevisiae AH22(pGA8701) in the National Collection of Yeast Cultures with the number NCYC 2345). The enzyme is heat labile and S. cerevisiae strains expressing the enzyme are suitable for use in the production of low carbohydrate beers. The cloned DNA also contains a strong promoter useful for directing the expression of other heterologous genes in S. cerevisiae. <IMAGE>
Description
AMYLOLYTIC ENZYME
This invention concerns amylolytic enzymes. More specifically, it concerns the cloning of an O(-glucosidase gene from Candida tsukubaensis in Saccharomyces cerevisiae, thereby providing the latter with improved characteristics, making possible the brewing of beer having a reduced carbohydrate content.
There is considerable interest in the brewing industry in the production of superattenuated low calorie beers (socalled "light" beers). Low levels of carbohydrate are achieved in these beers by the addition of fungal amyloglucosidases, generally from Aspergillus niger,
Aspergillus awamori, or Rhizopus delemar, either at mashing or during fermentation of the wort. These enzymes convert the non-fermentable dextrins in the wort into glucose, which can be metabolised by the yeast to produce alcohol.
Commercial preparations of amyloglucosidase are impure, however, and frequently behave in unexpected ways with unpredictable efffflcts on beer quality. For example, amyloglucosidases may interact with polypropylene glycol alginate in beer to form hazes. Contaminating proteases present in the enzyme preparation may also affect headretention. Furthermore, most fungal amyloglucosidases are not inactivated by pasteurisation, and may continue to break down dextrins during storage forming sugars which can no longer be fermented, giving rise to sweetness in the beer. Another disadvantage of using commercial enzymes is that they add to production costs. Consequently, there is a requirement for new brewing yeast strains capable of degrading wort dextrins during fermentation.
Both rare mating and protoplast fusion techniques have been used to generate hybrids between brewing yeast and the amylolytic yeast, Saccharomyces diastaticus. Brewing strains with similar fermentation and organoleptic characteristics to the parental yeast, plus exogenous amyloglucosidase, can be produced by these methods only if the POF1 gene, which is responsible for a detrimental "phenolic" off-flavour in beer, is eliminated .
Recombinant DNA techniques offer a more defined, specific route to the genetic modification of brewer's yeast. Perry and Meaden (J. Inst. Brew. 94, 64-67) have cloned the DEX1 (or STA2) gene of S.diastaticus into both lager and ale yeast and fermentation trials show that the yeast transformants can degrade up to 30% of the wort dextrins.
This corresponds to the degree of hydrolysis which one might expect from an enzyme which does not exhibit anyi 6 activity, and hence cannot completely break down starch and related oligosaccharides.
Genes coding for amyloglucosidases with debranching activity have been isolated from other yeasts and filamentous fungi, including Saccharomycopsis fibuligera,
Candida albicans. Aspergillus awamori, Aspergillus niger and Rhizopus sp. Expression and secretion of active amyloglucosidase has been achieved from laboratory strains of Saccharomyces cerevisiae transformed with the cloned genes. With the exception of the amyloglucosidase genes from S.diastaticus and A.niger, none of these genes have yet been introduced into brewing strains of yeast.
Unfortunately, all of these enzymes suffer from the disadvantage that they are not completely destroyed by pasteurisation.
Various genes from Candida species have, in the past been transferred into Saccharomyces cerevisiae. Kawamura et al.
in Gene. 24(1983) 157-162 describe the cloning of a LEU gene from C. inaltosa. Hsu et al. in Journal of Bacteriolo gy 154(1983), 1033-1039 describe the cloning of several DNA fragments from C. utilis into YIp5, thereby conferring onto Ylp5 the ability to replicate autonomously in S.
cerevisiae. Loper et al. in a paper published in US
Environ. Prot. Agency, Res. Dev. (Rep) EPA (EPA/600/984/015, Incineration treat, Hazard Waste), pp 274-281, describe the cloning of gene sequences from C. tropicalis into S. cerevisiae. Gillum et al. in Moi.Gen.Genet. (1984) 198: 179-182 describe isolation of a gene for orotidine 5- phosphate decarboxylase by complementation of
S.cerevisiae ura 3 mutations. EP-A-0173668 relates to the expression of certain functional DNA sequences from Candida species into Saccharomyces cerevisiae, especially as a means of studying agents for the treatment of Candidiasis infections.
De Mot et al (Antonie van Leeuwenhoek, 51, 275-287) have shown that the filamentous yeast Candida tsukubaensis CBS 6389 produces an extracellular heat labile amyloglucosidase.
We have now isolated a gene coding for a novel amylolytic enzyme from a genomic library of Candida tsukubaensis. We have expressed the gene in Saccharomyces cerevisiae. This enzyme has properties which make it suitable for use in the production of low carbohydrate beers. It is different in several respects from the amyloglucosidase enzyme mentioned by de Mot, as will be demonstrated below.
One embodiment of the present invention provides
Saccharomyces cerevisiae having an 0(-glucosidase gene from
Candida tsukubaensis CBS 6389.
A further embodiment of the invention provides a method of providing Saccharomyces cerevisiae with enhanced D(-glucosi- dolytic activity comprising transforming said
Saccharomyces cerevisiae with an α-glucosidase gene from a genomic library prepared from Candida tsukubaensis. Another embodiment of the invention provides a method of fermenting carbohydrate material comprising adding a culture of S.cerevisiae to an aqueous solution, suspension or dispersion of said carbohydrate material wherein the S.cerevisiae has an glucosidase gene derived from Candida tsukubaensis.
Another embodimetn of the invention provides a 4.39 Kb Bam H1 fragment having the nucleotide sequence set out in the accompanying Drawings.
Yet another embodiment of the invention provides a Bam H1
Xhol fragment extending from nucleotide 1-272 of the aboveidentified 4.39 Kb BamH1 fragment.
A further embodiment o-f the invention provides α-glucosidase obtained in an extracellular fraction of a culture of S.
cerevisiae modified by a gene for C.tsukubaensis CBS CBS 6389, as defined above.
The attached Drawings are provided to illustrate the invention, and will be explained more fully below.
Figs l(a) and l(b) are growth curves of clones showing
amylolytic enzyme activity.
Fig. 2 is a restriction map of a 4.39 Kb Bam H1 fragment from
a transformed yeast according to the invention;
Fig. 3 is a further restriction map;
Fig.4 is a graphical illustration of a strategy for
sequencing the 4.39 Kb fragment;
Fig. 5 is the nucleotide sequence of the 4.39 Kb fragment.
Fig. 6 shows amino acid sequences derived from the peptide
coded by the 4.39 Kb fragment.
Candida tsukubaensisd CBS 6389 was first described by Onishi in Antonie van Leeuwenhoek, 38 (1972), 365-367.
Chromosomal DNA was prepared from C. tsukubaensis by physical disruption of the yeast cells. Chilled cells were ground and solvent-extracted. Nucleic acids from the extract were digested with RNase in conventional manner.
The chromosomal DNA was partially digested with restriction endonuclease Sau 3A, and fractionated. Fragments from 2.5 to 20 Kilobases were used to compile the genomic library by ligation to Bam HI digested, dephosphorylated YEp 13 with
T4 DNA ligase.The resulting hybrid DNA was used to transform Escherichia coli=
The following abbreviations are used herein:
Ci, Curie; cpm, counts per minute; OC, degree Centigrade; [-32P] dGTP, Deoxyguanosine 5-[ot-32P] triphosphate; DNA,
Deoxyribonucleic Acid; EDTA, Ethylenediamine tetra acetic acid;
H, Histidine; Kb, Kilobase pair; L, Leucine; OD, Optical density;
PAGE, Polyacrylamide gel electrophoresis; rpm, revolutions per minute; SDS, sodium dodecyl sulphate; Tris, Tris (hydroxymethyl) methylamine; T, Tryptophane; U.V., Ultra violet.
SSC refers to a solution containing sodium chloride and sodium citrate. The method of preparation is given in Maniatis et al.
(1982): Molecular cloning : a laboratory manual, pub. Cold Spring
Harbor Laboratory, NY.
In the following, yeast strains were grown at 300C in complete medium (YEPD) containing 20g glucose per litre or in minimal medium containing Difco yeast nitrogen base w/o amino acids (0.67%) and either 2% glucose (YNBG) or 2% maltose (YNBM) as sugar source. HisSidine (20 pg ml-1), leucine (30 jig ml-1) uracil (20 jig ml-1) and tryptophane (20 jig ml-1) were added as required.
EXAMPLE 1
Preparation of chromosomal DNA
Because C.tsukubaensis cells were resistant to spheroplast formation using enzymatic treatment of the yeast cell wall, chromosomai DNA was obtained by a method involving physical disruption of the yeast cells. All centrifugation steps were carried out in a Sorvall SS-34 rotor using a Sorvall RC-5B refrigerated superspeed centrifuge at 40C. C.tsukubaensis cultures (100 ml) which had been grown to stationary phase in
YNBD at 240C for 6 days were harvested by centrifuging at 10,000 rpm for 10 minutes and washed once by resuspension in cold, distilled H2O. The cell pellet was drained of excess liquid and ground to a fine powder using a mortar and pestle and at least 1 litre of liquid nitrogen.The powder was then transferred carefully to a sterile centrifuge bottle and resuspended gently in 100mM Tris-HCl, pH 7.4., lmM EDTA., 1% (w/v) SDS at a final ratio of 5g wet weight of cells/100 ml solution. The viscous suspension was extracted three times with equal volumes of phenol:chloroform:isoamyl alcohol (25:24:1 v:v:v: equilibrated in l0mM Tris-HCl, pH 8.0, lmM EDTA), with intermediate separation of the aqueous and organic phases by centrifuging at 12,000 rpm for 10 minutes and finally, extracted once with an equal volume of chloroform:isoamyl alcohol, (24:1 v:v).Nucleic acids were precipitated by adjusting the aqueous fraction to 0.1M NaCl (from a 5 M NaCl stock solution) followed by the addition of 2 volumes of cold absolute ethanol (-200C), and were subsequently collected by centrifuging ate7,000 rpm for 10 minutes.The resulting nucleic acid pellet was dried in vacuo and redissolved in l0mM Tris-HCl, pH 8.0, lmM EDTA (TE, pH8.0) Pancreatic RNase A (Sigma, 10 mg/ml in l0mM Tris-HCl, pH 7.5, 15mM NaCl heated to 1000C for 15 minutes to render DNase free and stored in aliquots at -200C) and T1 RNase (Sigma, 200, 000 U/ml in 2.7 M (NH4)2SO4, 20mM Tris-HCl, pH 6.0) were added to final concentrations of 100 ug/ml and 100 U/ml, respectively, and RNA was digested during an overnight incubation at 40C. The nucleic acid mixture was then further deproteinized by extraction (twice) with equal volumes of phenol:chloroform with separation of the phases by centrifuging at 7,000 rpm for 10 minutes followed by a chloroform extraction.
High molecular weight chromosomal DNA was precipitated by adjusting the aqueous fraction to 0.1M NaCl (from a 5M NaCl stock) followed by the addition of 0.6 volumes of isopropanol.
After 15 minutes at room temperature, the DNA was collected by centrifuging at 7,000 rpm for 10 minutes. The chromosomal DNA pellet was rinsed once in 70% (v/v) aqueous ethanol, dried in vacuo and redissolved in a sterile TE buffer (pH 8.0).
Plasmid DNA isolation and transformations
Plasmid DNA was isolated from E.coli using the rapid alkaline lysis extraction procedure of Birnboim and Doly Nucl. Acids
Res., 7(6) (1979) 1513-1523, and purified by CsCl-ethidium bromide equilibrium density gradient centrifuging. E.coli was routinely transformed by the CaC12 competent cell method of
Mandel and Higa as described by Lederberg and Cohen: J.
Bacteriol; 119(3) (1974) 1072-1074. Yeast spheroplasts were transformed essentially as described by Hinnen et al. Proc.
Natl. Acad. Sci. USA 75(4), (1978) 1929-1933, while intact yeast cells were made competent and transformed using the lithium acetate method of lto et al: J. Bacteriol; 169(9) (1983) 41714176. Plasmid DNA was recovered from transformed yeast cells as described by Hoffman and Winston: Gene, 57 (1987) 267-272 and used to transform E.coli using the CaC12 /RbCl procedure of
Kushner as set out gn "Genetic Engineering" Ed. Boyer & Nicosia,
Elsevier (1978) pp. 17-23.
Construction of C.tsukubaensis genomic library
Candida tsukubaensis chromosomal DNA (100 yug) was partially digested with the restriction endonuclease Sau 3A, using a ratio of enzyme:DNA of 0.1:1 units DNA at 370C for 10 minutes, and was subsequently fractionated on a linear 5-208 (w/v) sucrose gradient (in lOml of 20 mM Tris-HCl. pH 8.0,, 5mM EDTA, 1M NaCl) by equilibrium density gradient centrifuging (39,000 rpm for 5.5 hours at 15-19 0C in a Sorvall TH 641 rotor). Individual gradient fractions (0.5ml) were collected, aliquots were analysed by agarose gel electrophoresis and fractions containing DNA fragments ranging from 2.5-20 kilobases (Kb) were pooled and used for library construction.These DNA fragments were ligated to
BamHI digested, dephosphorylated YEpl3 with T4 DNA ligase at an insert to vector ratio of 1:1 (12.5 ug:12.5 ug insert:vector).
This pool of hybrid DNA molecules was used to transform E.coli
JA221 to AMPr and the transformants were stored as pools at -700C in 15% glycerol.
DNA hybridisation
DNA depurination, denaturation, and neutralization followed by
Southern transfer of fractionated chromosomal DNA digestions from agarose gels onto nylon filters (Hybond N; Amersham) were carried out as described by Southern in J.Mol. Biol. 98 (1975), 503-517 but included modifications recommended by the supplier when using nylon membranes. A radiolabelled DNA probe was prepared by the incorporation of i-32P-dGTP (lOmCi / ml, 3,000 Ci/ mmol) into the recessed 3' ends ofitamHI digested plasmid pGA8701 in a fill - in reaction catalysed by the Klenow fragment of E.coli DNA polymerase: Drouin: J. Mol. Biol, 140(1980), 15-34. The 4.3 kb
BamHI radiolabelled probe (subfragment of the 6.2 kb Sau3A cloned fragment) was separated from host vector sequences by fractionation on 0.8% agarose followed by DNA extraction of the required fragment from the gel, according to Vogelstein and
Gillespie, Proc. Natl. Acad. Sci. USA, 76(2), (1979), 615-619.
Filters were prehybridised for 3-4 hours at 650C in 6 X SSC, 5 x
Denhardt's solution, 0.5% (w/v) SDS containing the denatured radiolabelled probe (heated to 1000C for 15 minutes and cooled; 106-107 cpm/ml hybridisation solution). Filters were subsequently washed under conditions of successively increasing stringency, by raising the washing temperature and/or decreasing the salt concentrations in the washing solution, followed by autoradiography at -700C with Fuji RX film and intensifying screens.
Enzyme Assays
Amylolytic enzyme activity measurements were based on the colorimetric determination of free glucose liberated from 2%
(w/v) substrate in 50mM of McIlvaine buffer, at the specified pH, time and temperature. Standard assay conditions were 60 minutes at 50 C using 2% maltose or 2% dextrin (in 50mM of
McIlvaine buffer, pH 5.4) as substrate. The reaction was stopped in boiling water for 10 minutes and the glucose concentration estimated using the Glucose oxidase - Peroxidase diagnostic kit (Sigma Diagnostics Procedure N0510) or that supplied by Boehringer Mannheim GmbH (Test-combination glucose).
One unit of enzyme activity is defined as that amount of enzyme which liberates 1 uMol of D-glucose per hour under the conditions 3 of the assay.
Molecular cloning of a gene coding for an amylolytic
enzyme from C.tsukubaensis
The genomic library constructed in E.coli JA221 contained some 40-50,000 independent transformants, 94% of which were judged to be recombinants due to insertional inactivation of the vector based tetracycline gene. As the Candida tsukubaensis genome is about 2 x 104 kb in size, 8 x 103 independent transformants carrying an insert of about 10 kb are required to provide a genomic library in which each of the C.tsukubaensis gene sequences will be represented at least once with a 99% probability. On the basis of this estimation, the C.tsukubaensis - YEpl3 library should contain more than one copy of every gene.
Recombinant library (Candida tsukubaensis-YEpl3) plasmid DNA was amplified and purified from E.coli JA221 transformants, and aliquots of the library DNA were used to transform S.cerevisiae
AH22 with initial selection of yeast transformants based on complementation of the leu 2 gene. Three individual libraries of
S.cerevisiae AH22 (C.t - YEpl3) transformants were generated, and each library was estimated to contain 1.0 to 1.5 x 104 LEU+ transformants. S.cerevisiae AH22 LEU+ transformants were recovered from the regeneration media, were pooled and inoculated directly into YNBG,H medium. The transformants were then grown overnight at 300C.
Fractions of the S.cerevisiae AH22 (C.t. - YEpl3) library cultures were then either stored at -700C in 15% glycerol or plated directly onto appropriate selection media for the identification of recombinants expressing the desired phenotype.
Detection of S.cerevisiae AH22 transformants with amylolytic properties was initially based on screening for colonies growing on synthetic media containing either dextrin (YNBD,H) or starch (YNBS,H) as the major carbon source. Fractions of the pooled
S.cerevisiae AH22 (C.t. - YEpl3) recombinant libraries, represented by some 3 to 4.5x104 independent transformants, and serial dilutions thereof were plated on the appropriate selection medium (YNBD, H or YNBS,H) at cell densities ranging from 2x103 to 2x105 cells/plate, and the plates were incubated at 300C.
After 10 days incubation at 300C, two very strongly growing colonies were evident on dextrin - containing plates (these clones were named DEX 1 and DEX 2). Each of these putative 'amylolytic clones' was confirmed to have a HIS phenotype and was morphologically identical to the host strain S.cerevisiae
AH22 on microscopic examination. Initial characterisation of amylolytic clones was based on comparisons of their growth rates on selection plates containing either dextrin or starch as sole carbon sources relative to the growth displayed by the nonamylolytic S.cerevisiae AH22 host strain (Meaden et al., Gene, 34(1985), 325-334), which acted as a negative control, and that of the amylolytic yeast S.diastaticus ATCC 28339 which acted as a suitable positive control.DEX 1 and DEX 2 grew better on both dextrin and starch media than the control strain, S.cerevisiae
AH22; and DEX 1 and DEX 2 appeared to grow marginally faster on dextrin than on starch. In addition, they produced clear haloes around areas of growth on starch plates held at 40C for 2-3 days, similar to the clearing displayed by the control strain
S.diastaticus ATCC 28339, indicating starch degradation. On the basis of this, clones DEX 1, and DEX 2 were studied for dextrinase activity and cell density. Exponentially growing cultures were inoculated into a selective synthetic medium containing dextrin (YNBD,H) and incubated at 300C. Cell densities (Figure 1(a)) of the recombinant cultures S.c. AH22 DEX 1 (ski), S.c. AH22 DEX 2 (+)., and S.c.AH22 YEpl3 (*) as control were estimated by measuring the absorbance at 600nm (OD600 nm/ml). Dextrinase activity (Figure l(b)) in the corresponding culture supernatants was measured by determining the glucose liberated (moles) per ml enzyme solution from 2% dextrin (in 50 mM McIlvaine buffer, pH 5.4) at 500C in 1 hour.
The favourable growth rates of clones DEX 1 and DEX 2 relative to that of S.cerevisiae AH22 (YEpl3) in this medium coupled to the detection of low levels of dextrinase activity (1-2 Fmoles glucose / ml liberated in 1 hour at 500C) in the culture supernatants of DEX 1 and DEX 2 was taken as positive confirmation that these clones contain a gene encoding an enzyme capable of degrading dextrin and that this gene is expressed and secreted by S.cerevisiae.
Plasmid curing
Plasmid curing experiments were carried out to confirm that the amylolytic properties of DEX 1 and DEX 2 were due to a recombinant plasmid gene function and not to a mutation in the genome of the host strain S.cerevisae AH22. Each clone was initially grown for about 10 generations (15-16 hours) non-selectively at 300C in MYGP medium, plated onto complete synthetic medium (YNBG, H, L) and incubated at 300C for a further 3 days. Individual colonies were tested for the concomitant loss of both the leu 2 gene (by plating onto YNBG medium lacking leucine) and of the ability to grow on dextrin as sole carbon source (by plating onto YNBD supplemented with both leucine and histidine). Of a total of 100 DEX 1 colonies tested, 49 colonies had lost the LEU 2 phenotype and the ability to grow on dextrin. The remaining colonies retained the ability to complement leu 2 and the ability to grow on dextrin. Similarly, of a total of 100 DEX 2 colonies tested, 53 colonies which retained the plasmid LEU 2 phenotype also retained the dextrinase phenotype. DEX 2 colonies which had been cured of the plasmid failed to grow on dextrin medium.
Further confirmation of these results was provided by examination of a random sample of 40 colonies originating from DEX 1 and DEX 2 cultures, 20 of which were found to have retained and 20 of which had lost the plasmid LEU2 phenotype. The individual colonies were grown in synthetic medium containing dextrin (YNBD,H) at 240C for 7 days apd then monitored for growth by measuring the increase in optical density at 600nm and production of dextrinase activity in culture supernatants.
In all cases examined, colonies which retained the LEU+ phenotype were found to grow better on YNBD medium, reaching cell densities (assessed via the increase in optical density) some 3 to 4 fold greater than colonies which had lost the plasmid. In addition, the former colonies secreted low but detectable levels of dextrinase into the culture medium. These results confirmed that the ability to degrade dextrin in the medium was due to the presence of a recombinant plasmid in DEX 1 and DEX 2 clones.
Transformation of S.cerevisiae DBY746
To obtain further confirmation that the ability of DEX 1 and DEX 2 to degrade dextrin in the medium was due to a plasmid encoded function, it was necessary to establish if plasmids recovered from these clones could confer similar amylolytic properties on other strains of S.cerevisiae.
DNA recovered from freshly grown cultures of DEX 1 and DEX 2 (grown in YNBG,Eie at 300C for 24 hours) was initially transformed into E.coli JA221 in order to facilitate plasmid amplification and purification. Plasmid DNA which originated from DEX 1 was designated pGA8701 and that from
DEX 2 was designated pGA8702. Plasmid DNA isolated from the AMPr, TEXTS E.coli transformants was then used to transform competent cells of S.cerevisiae DBY746 with selection for complementation of the LEU phenotype.
Individual LEU+ transformants were then analysed for their ability to grow in synthetic medium containing dextrin (YNBD, H,U,T) at 300C; cell densities (OD600nm) were measured and the culture supernatants were assayed for the presence of dextrinase activity. All of the S.cerevisiae
DBY 746 transformants containing pGA8701 or pGA8702 achieved cell densities some 2 to 3 times greater than the control strain S.cerevisiae DBY746 (YEpl3) following 3 days incubation at 300C in selective YNBD medium; the low, but detectable levels of dextrinase activity present in the culture supernatants of the former strains was interpreted as confirmation that the production of amylolytic enzyme by
DEX 1 and DEX 2 was due to C.tsukubaensis DNA sequences cloned in YEpl3.
Restriction endonuclease mapping
A restriction endonuclease map of the plasmids pGA8701 and pGA8702 originating from DEX 1 and DEX 2 was prepared in order to characterize the recombinant DNA inserts. Initial restriction endonuclease mapping experiments revealed that the recombinant plasmids pGA8701 and pGA8702 each contained a 6.2 kb DNA insert flanked by Sau 3A recognition sites.
More detailed analysis of the recombinant DNA showed that the plasmids shared identical restriction patterns for
BamHI, SalI and HindIII and that both recombinant plasmids shared the same insert orientation with respect to host vector sequences. In view of the near identical behaviour of the recombinant clones DEX 1 and DEX 2 with respect both to growth characteristics on YNBD and to production of amylolytic enzymes, it was assumed that DEX 1 and DEX 2 were independent isolates of the same clone. Consequently only plasmid pGA8701, isolated from DEX 1, was subjected to further analysis. Single and double restriction digests of pGA8701 with various restriction endonucleases showed that the 6.2kb cloned insert contained 4 sites for SalI, 3 sites for PvuI, 2 sites for BamHI, EcoRI and HindIII and 1 site for XhoI and PstI.There were no sites on the cloned fragment for HpaI, PvuII, XbaI or BclI. Fig. 2 is detailed restriction map of the insert in pGA8701.
In addition to the recognition sites given in Fig. 2, there are no sites on the cloned fragment for the restriction endonucleases Hpa I, Pvu II, Xba I or Bcl I. The Sau 3A restriction endonuclease sites, at nucleotide positions 1, 6200 bp, which flank the cloned insert present in the recombinant plasmid pGA8701 are included but internal Sau 3A recognition sites were not mapped.
Southern blot analysis
In order to verify the genetic origin of the cloned fragment encoded by the recombinant plasmid pGA8701 and to investigate the existence of possible homologies between the insert fragment and DNA sequences from other strains of yeast, a radiolabelled subfragment of the 6.2 kb cloned insert was used to probe total genomic DNA isolated from a variety of yeast strains. Chromosomal DNA was prepared from S.diastaticus ATCC 68339, S.cerevisiae AH22, S.
cerevisiae DBY746, S.cerevisiae 1164 (ale yeast),
S.cerevisiae 3804A (ager yeast), Sch.occidentalis CBS 819 and C.tsukubaensis CBS 6389. Aliquots (10 sg) of each preparation were digested to completion with the restriction endonuclease BamHl and fractionated by agarose gel electrophoresis. The DNA fragments were transferred to a nylon filter and probed with a 32P-labelled 4.3 kb BamHI fragment isolated from pGA8701.
The hybridisation results clearly showed that the labelled probe specifically hybridised to a 4.3 kb DNA fragment from the BamHI digested chromosmal DNA from C.tsukubaensis CBS 6389, even under highly stringent washing conditions (by washing the filters successively in 2 X SSC 15 minutes; 2 X
SSC, 0.1% (w/v) SDS, 30 minutes; 0.1 X SSC, 10 minutes at a hybridisation temperature of 650C) thereby providing confirmation of the genetic origin of the cloned fragment in pGA8701.
No hybridisation was observed between the labelled probe and the other specimens of yeast chromosomal DNA screened, even under low stringency washing conditions (by washing the filters successively in 6 X SSC 5 minutes; 6 X SSC 0.1% (w/v) SDS, 2 x 5 minutes; 6 x SSC, at 370C) indicating the complete absence of homology between the cloned gene fragment and other yeast DNA, including the amylolytic yeast strains S.diastaticus ATCC 28339 and Sch.occidentalis
CBS 819.
Characterisation of properties of the cloned enzyme
The biochemical properties of the enzyme encoded by pGA8701 from DEX 1, were examined and compared with values reported for the amyloglucosidase secreted by the donor strain C.tsukubaensis referred to above and described by
DeMot et al. Antonie van Leeuwenhoek 51(1985), 275-287.
Determination of substrate specificity
Culture supernatant concentrates of S.cerevisiae AH22 (pGA 8701) grown in YNBD, H were used as enzyme source.
Fractions were assayed for enzyme activity using 2% (w/v) substrates (in 50mM McIlvaine buffer, pH 5.4) at 500C for 30 minutes; activities were calculated on the basis of the amount of D-glucose ,moles) liberated per ml enzyme solution in 30 minutes. Relative activities were expressed as percentages (%) relative to the enzymic activity displayed with 2% (w/v) maltose as substrate under the specified conditions.
Table 2 sets out the relative activities of the cloned enzyme
towards 22 different substrates. Four classes of
enzymatic activity for the cloned enzyme may be
distinguished on the basis of the type of sugar linkage
hydrolysed. The enzyme displayed an unusually broad
substrate specificity, being capable of acting on (1,6), K(1,3), andα;(1,2) linkages, as well as on aryl
and to a lesser extent on alkyl- -D-glucosides. A marked
preference for the lower molecular weight oligomeric
substrates was evident, which quite clearly distinguishes
this enzyme from the amyloglucosidase of C.tsukubaensis CBS
6389 described by DeMot et al., and also from other
amyloglucosidases which typically exhibit substrate
preferences for the more complex carbohydrates of dextrins
and starches. Maltose was the preferred substrate, with
comparatively high activities displayed towards the tri
and tetra - glucose oligomers of maltotriose (598) and
maltotetraose (48%), respectively.Dextrin acted as a
moderately poor substrate (activities ranging from 6.4 to
8.0% relative to maleose, depending on the preparation of
dextrin examined) and the enzyme displayed little or no
affinity for starch (0 to 0.7% activity relative to
maltose depending, on the starch preparation used);
pullulan was not hydrolysed. The amyloglucosidase produced
by C.tsukubaensis CBS 6389 described by de Mot displayed an
entirely different substrate specificity profile, with
dextrin and starch featuring as the preferred substrates.
In fact, the substrate specificity profile of our cloned
enzyme appears to resemble the profiles exhibited by- glucosidases more closely than those of amyloglucosidases.
Alpha-glucosidases (X-D-glucoside glucohydrolase E.C.
3.2.1.20), have been defined as enzymes which hydrolyse
terminal, non reducingQQ-i;4 andOQ-l,6 linked glucose residues in different substrates releasing -D-glucose; they degrade disaccharides and oligosaccharides rapidly, relative to larger structures and polysaccharides are attacked slowly if at all. Characteristically, although - D-glucosidases are believed to be highly specific for glucose residues, their specificity for the aglycon portion of the substrate is not as distinct and thus, maltose, maltose derivatives, sucrose and related fructosyl-i- glycosides, aryl - and alkyl-g -glucosides may act as substrates to varying degrees depending on the particular enzyme isolate.On the basis of the above definition, our cloned enzyme may be classified as an-α-glucosidase, in that maltose and derivatives are the preferred substrates, with the more complex polysaccharides being hydrolysed more slowly or not at all (Table 2). Sucrose is a moderately good substrate (55% activity relative to maltose) with the derivative melezitose hydrolysed somewhat more slowly (8.8% activity relative to maltose). Our cloned enzyme hydrolysed phenyl- < -D-glucoside and i-methyl-D-glucoside at rates of 18% and e0.7% relative to that of maltose, respectively.It also displayed relatively good hydrolysis of O(-(l,6) linked glucose units as indicated by the relative activities of 35% with isomaltose -D-glucose (1,6)-i-D-glucose) and that of 55% with panose glucose (1,6)-6-D-glucose - (1,4)-D-glucose) and, interestingly, also displayed some activity towards (1,3) linkages, as indicated by the hydrolysis of turanose (4.1% activity relative to maltose).
Determination of pH optimum
The activity of the enzyme at pH 3.4, 3.9, 4.2, 4.4, 4.6, 4.9 and 5.4 was determined. The optimum was found to be within the range from 4.2 to 4.6, (see Table 3). No sharp
dependence on pH was observed, with more than 90% of enzyme
activity remaining over a range of 1 pH unit from pH 3.9 to
4.9. The enzyme clearly differs from the amyloglucosidase
of C.tsukubaensis CBS 6389, which displayed highest
activity over a much broader pH range of 2.4 to 4.8.
Determination of temperature optimum
The activity of the enzyme was examined over a range of
temperatures (20 to 650C) in order to determine its optimum
temperature. The results obtained (Table 4) clearly
indicated that the optimum temperature lay within the
range from 55 to 600C, with marginally greater activity
displayed at 580C. Increasing the temperature of
incubation to 650C resulted in a sharp inactivation of the
enzyme, leaving only 40.4% of the activity observed at
580C. De Mot et al. reported that the purified
amyloglucosidase secreted by the donor strain
C. tsukubaensis CBS 6389 had a temperature optimum of 550C
with relative activities of 70% and 26% observed at 600C
and 650C respectively.
Thermostability at 600C
For the determination of the thermostability of the cloned -glucosidase enzyme, S.cerevisiae AH22 (pGA 8701) was grown
in dextrin containing medium (YNBD, H) for 3 days at 240C;
culture supernatants were assayed at 550C for 1 hour using
2% maltose (in 50 mM McIlvaine buffer, pH 5.4) as substrate
following preincubation at 600C for 0,1,2,5,10,20, and 60
minutes. The results obtained clearly indicate (Table 5)
that the enzyme, when grown in YNBD,H, containing medium,
was inactivated following incubation at 600C for 5 minutes.
Similar results were reported by De Mot et al. for the
amyloglucosidase from C.tsukubaensis CBS 6389.
Estimation of molecular weight
The protein profiles of culture supernatants of
S.cerevisiae AH22 (pGA 8701) were analysed and compared with the corresponding protein profiles from culture supernatants of a control strain S.cerevisiae AH22 (YEpl3) by analytical SDS polyacrylamide gel electrophoresis in order to identify the cloned % -glucosidase gene product.
The levels of g-glucosidase activity produced by
S.cerevisiae AH22 (pG8701) grown in either dextrin, maltose or glucose containing synthetic medium were equivalent and those levels of g -glucosidase enzyme activity expressed were directly proportional to the cell densities of the cultures when grown under identical conditions of temperature and time, thereby suggesting that expression of the cloned -glucosidase gene is constitutive and is not subject to glucose repression. Thus in order to facilitate growth of the control strain to cell densities comparable to those of the recombinant S.cerevisiae AH22 (pGA 8701), cultures (100 ml) were grown in a synthetic medium containing glucose as carbon source (YNBG, H) at 240C for 3 days. Protein was concentrated 500-fold from the culture supernatants (after centrifuging at 5,000 rpm, 10 minutes, 40C) by repeated acetone precipitation followed by solution in a minimal volume of double distilled H20. The protein contained in 5-50 ml of culture supernatant was then analysed by SDS-PAGE. Direct comparison of the protein profiles revealed the presence of a somewhat diffuse protein band in the culture supernatants of the recombinant strain S.cerevisiae AH22 (pGA 8701) which was not present in the supernatant of the control strain S.cerevisiae AH22 (YEp 13). The molecular size of the proposed i- glucosidase peptide was estimated to be about 75,000
daltons.On treatment of the above culture supernatant
concentrates with Endoglycosidase H, two bands were evident
in the protein profiles of the recombinant strain
S.cerevisiae AH22 (pGA8701) which were not present in that
of S.cerevisiae AH22 (YEp 13) control and not present in
corresponding untreated controls. The molecular sizes of
the two polypeptides were judged to be 65,000 (peptide 1)
and 52,000 (peptide 2) daltons, approximately. This
suggests that pGA 8701 encodes not one but two protein
products which are glycosylated in S.cerevisiae AH22.
I.
Localisation of the i-glucosidase gene on pGA 8703
Plasmids pGA8703 and pGA8704 differing only in the
orientation of the insert relative to the vector plasmid
were constructed by transferring a 4.39 Kb BamHl fragment
of C.tsukubaensis DNA which contains the C.tsukubaensis O(-glucosidase gene from pGA8701 into the BamH1 site of YEp24
and transformed into S.cerevisiae DBY 746. The restriction
map of this 4.39 Kb BamHl insert is shown in Fig. 2 of the
accompanying Drawings. To localise the OY-glucosidase gene,
various deletion derivatives were constructed in YEpl3 and
introduced into S.cerevisiae AH22.Plasmids
pGA8801/pGA8802 were constructed by first subcloning a Pstl
fragment containing the yeast Ura3 gene and a BamHl-Pstl
fragment of Candida DNA from pGA8703 into pUC1318 to give pGA8710. The BamHl-Pstl fragment was then recovered from pGA8710 as a BamHl fragment and inserted into YEpl3. The
plasmids pGA8812/pGA8813 were derived from the 4.39 Rb BamHl fragment by deleting an internal 1.6 Kb Pvul fragment
and transferring the deleted fragment into YEpl3.BamHl
linkers were added to the Ndel and Mlul sites flanking the BamHl-Ndel and BamHl-Mlul fragments before subcloning into
the BamH1 site of YEpl3 to generate the recombinant plasmids pGA8817/pGA8818 and pGA8912/pGA8913. The
S. cerevisiae transformants were screened for ability to grow in yeast minimal medium containing maltose as sole carbon source and for the presence of α-glucosidase activity in culture supernatants.
Only recombinant plasmids which contained the entire 4.39
Kb Basal fragment or the 3.46 Kb BamHl-Mlul fragment produced α-glucosidase. Moreover, α-glucosidase activity was detected only when the BamH1 or BamBl-Mlul fragments were inserted into the cloning vectors YEp24 or YEpl3 in the same relative orientation i.e. the reverse orientation with respect to the direction of transcription initiation from the Tetr gene promoter.These results, together with other observations on the expression of C(-glucosidase S.cerevisiae recombinant plasmids containing the yeast GAL 1-10 promoter and CYC-l terminator sequences, led to the conclusion that the direction of α-glucosidase gene transcription was, 5' - 3', from the BamH1 site at nucleotide 1 through to the Mlul site at nucleotide 3,468.
In addition, because the relative levels of -glucosidase activity expressed by the positive recombinant plasmids were roughly equivalent, irrespective of whether the entire 4.39 Kb BamHl fragment or the smaller BamHl-Mlul fragment was present, it was evident that the 3.46 Kb BamHl-Mlul fragment contained the entire DNA sequence necessary for the expression of the CX-glucosidase gene in S.cerevisiae.
DNA sequence determination
The nucleotide sequence of theC < -glucosidase gene transferred was determined in conventional manner, and is set out in Fig. 5 of the accompanying Drawing.
In order to facilitate DNA sequence determination of the
entire 4.39 Kb BamHl fragment containing theO(-glucosidase gene, the series of recombinant plasmids pTS 001 to pTS
015 was constructed by cloning subfragments into the appropriate sitess within the polylinker region of the vector pUC8 as illustrated in Fig. 3.
To facilitate construction of plasmids pTSOl4 and pTSOl5, BamHl linkers were added to the filled in Ndel sites before inserting the fragments into pUC8. DNA inserts from a selection of these plasmid constructs were then cloned directly into the bacteriophage M13 derivatives mpl8 and mpl9 rf DNA as specified in Table 6. Nucleotide sequencing was carried out using the dideoxy sequencing method according to the strategy outlined in Fig. 4, which is the restriction map and sequencing strategy for the 4.39 Kb BamHl fragment containing the g -glucosidase gene. The arrows indicate the direction and extent of nucleotide sequence determinations. Symbols denoting restriction endonuclease recognition sites are B, BamHl; H, HindIII; M, MluI; N,
NdeI; P, PstI; S, SalI; X, XhoI; Pv; Pvul.The vertical lines indicate the positions of restriction sites and the o indicate use of custom made synthetic oligonucleotides as primers in extension reactions. This was carried out using either the double stranded plasmid DNA or single stranded phage DNA as specific templates and universal, reverse or custom made oligonucleotides as primers in the extension reactions.
The complete sequence of the 4.39 Kb of cloned DNA which contains the < -glucosidase gene is shown in Fig. 5. The first nucleotide of the BamBl site at the extreme left of the fragment (Fig. 1) was set as nucleotide 1 of the sequence. A single open reading frame (ORF 1) of 3,210 bp extending from nucleotide 170 to 3,380 was identified in
reading phase 1. A second open reading frame ORF2 was
identified in reading phase 2 of the nucleotide sequence
which extended from nucleotide 3,858 to 4,368. No introns
were detected.Because the entire coding sequence of the
peptide encoded by ORF 2 lies downstream from the Mlul
restriction endonuclease recognition site (Fig. 2) and
because the sequences downstream from this site are not
required for the expression of O( -glucosidase activity in
S.cerevisiae transformants, we conclude that the peptide
corresponding to ORF 1 represents the C.tsukubaensis O(-glucosidase gene. The function of the gene encoded by ORF
2 is not known.
Analysis of the%-glucosidase coding region
The predicted amino acid sequence of the-glucosidase gene
encoded by ORF1 isas shown in Fig. 5. Assuming that
translation initiation begins at the first in-frame AUG at
the extreme 5' end of the mRNA, as proposed by the Ribosome
Scanning Model for translation initiation in eukaryotes:
Kozak; Nucl. Acids.Res., 9 (20), (1981) 5233-5250, then
translation of the -glucosidase mRNA, must begin at
nucleotide 170 and proceed through to and terminate at the
first in-frame stop codon located at nucleotide 3,380 to
encode a single polypeptide of 1,070 amino acids with a
calculated molecular weight of 119 KDa.
Analysis of the nucleotide sequence of ORF 1 shows that
there are 24 potential glycosylation sites as defined by
the sequences Asn-X-Ser or Asn-X-Thr (Fig. 5). This was
consistent with the results of Endoglycosidase H
experiments which demonstrated that the cloned C(-glucosidase gene which is expressed and secreted by
S.cerevisiae is extensively glycosylated. It is not known
if all of these sites are actually glycosylated.
The deduced protein coding sequence of ORF 1 was searched for regions showing homology to the amino acid sequences found at the N-termini of peptide 1 and peptide 2 (Fig. 6).
Two regions of extensive sequence homology were clearly identified, namely, 9 of the 14 residues assigned to peptide 1 were homologous to amino acids 36-49 of ORF 1 while 17 of the 22 residues assigned to peptide 2 were homologous to amino acids 613-634 of ORF 1. If it is assumed that any mismatches are due to protein sequencing artifacts, then the extent of sequence homology is such that the amino acid sequences shown in Fig. 6 which have a been deduced from ORF1 must be identical with those found at the N-termini of peptides 1 and 2.
In Fig. 6, regions within i-glucosidase precursor protein (ORF 1) showing homology to the N-terminal amino acid sequences of peptide 1 and peptide 2 are shown . The numbers refer to the position of amino acids within the sequence and the * indicate matching amino acids.
Therefore, ORF 1 appears to encode a precursor polypeptide which is processed in a series of post-translational proteolytic processing steps to yield peptides 1 and 2. If proteolytic processing occurs at or around the areas showing sequence homology to the amino acid residues at the
N-termini of peptide 1 and peptide 2, then ORF 1 must be processed to yield two polypeptides, the larger of which corressponds in size to peptide 1 and extends from amino acid residues 36-613 with a predicted molecular weight of 64 KDa. A second polypeptide corresponding in size to peptide 2 extends from amino acid residues 613-1017 of ORF 1 and has a predicted molecular weight of 51.1 KDa.
Such a process step would, of course, necessitate removal of a short peptide of 36 amino acid residues from the N-terminal end of ORF 1. In view of the fact that the matureO(-glucodidase is found in the extracellular fraction of S.cerevisiae cultures it is possible that this N-terminal peptide may be acting as a signal sequence. The amino acid sequence of the N-terminal extension of ORF 1 was screened for properties typical of yeast signal sequences, as exemplified by the yeast PHO 5 encodes acid phosphatase described by Meyhack et al.,EMBO J,1 (6) 675-680 (1982), and the SUC 2 encoded invertase described by
Taussig and Carlson, Nucl. Acids Res. 11(6), 1943-1954 (1983).
The proposed signal sequence shared the following typical features with classical signal sequences as described by Perlman & Halvorson, J. Mol. Biol. 167(1983), 391-409, and by Von Heijne,
J. Mol. Biol. 184,(1985), 99-105:
(a) a positively charged N-terminal amino acid region
(containing one Lys and one Arg residue);
(b) a central hydrophobic core sequence;
and
(c) a more polar carboxy terminal region which
defines the cleavage site.In the case of their glucosidase protein, the hydrophobic core sequence
ends with the sequence Leu-Ala-Leu at amino acid
residues 24-26 and is following by a short stretch of
hydrophilic amino acid residues (extending from amino
acid residues 26-35)
Analysis of the codon usage patterns of the 0(-glucosidase precursor and of the flanking transcriptional and translational regulatory sequences, confirms that the C. tsukubaensis0(- glucosidase gene sequence contains many of the canonical features associated with highly expressed S. cerevisiae genes.
The Genbank and NBRF/PIR protein sequence databases containing 12,940 and 8,587 individual sequence entries, respectively, were searched for proteins showing homologies to the e cloned C(-glucosidase defined by ORF 1 and the unidentified protein defined by ORF 2. Homology scores were assigned according to the number of direct amino acid matches with credit given for conservative amino acid changes and downweightings where gaps were introduced to allow for sequence aAignments.
No entry was identified which showed significant homology to the polypeptide encoded by ORF 2 and it is not, therefore, possible to speculate as to the possible identity or biological role of ORF2. In the case of ORF 1, however, one high score indicating significant matching of sequences was obtained from both database searches. The sequence showing homology to ORF 1 is the sucraseisomaltase complex from rabbit intestinal mucosa; Hunziker, et al. Cell, 46, (1986) 227-234.
This sucrase-isomaltase complex (EC 3.2.1.48) is synthesized as a single chain precursor (pro SI) of approximately 260,000 daltons which possesses both enzymatic activities. This precursor is proteolytically processed by the action of pancreatic pro teasers into two
individual subunits, isomaltase (of approximately 140 KDa
daltons corresponding to the amino terminal portion of
proSI) and sucrase (of approximately 120 KDa daltons).
The promoter
Analysis of the DNA sequence encoding the C. tsukubaensis i-glucosidase gene suggests that there is an efficient
yeast promoter at the extreme 5' end of the 4.39Kb BamHl
fragment. This has been confirmed by experiment. We have
therefore provided a means of directing the expression of
other heterologous genes in S.cerevisiae, making use of the
fragment.
The fact that the gene comprises a yeast promoter is shown
by the ability of the BamHl-Xhol fragment, which extends
from nucleotide 1-ç72, to direct the expression of a
foreign gene (the -galactosidase of Escherichia coli) in S. cerevis iae.
This was confirmed using an E.coli-yeast shuttle vector, YEp
365, in which the lacZ gene is inactive due to lack of an
initiator methionine codon and absence of a promoter (Myers
et al., Gene, 45, 299-310, 1986). This vector will express ss -galactosidase in yeast only when the lacZ gene is fused in
phase to another gene possessing its own promoter. As
S.cerevisiae has no endogenousss-galactosidase activity, the
quantity of enzyme produced by the hybrid vector in yeast
is a function of the strength of the promoter used. Thus,
an efficient yeast promoter at 5' end of the 4.3Kb BamHl fragment would lead to in-frame fusion of the 272bp BamHl
Xhol fragment to the lacZ gene in YEp 365 to result in the
production of large amounts of R-galactosidase.
This 272bp fragment containing 170 nucleotides of 5'noncoding sequence and 34 amino acids of the i-glucosidase gene was cloned as a BamHl fragment into the unique Basel site of YEp365 and the resulting recombinant plasmid was designated pGA8904. pGA8904 contains the i-glucosidase gene fused in-frame to lacZ. S.cerevisiae AH22 cells transformed with pGA8904 ! formed blue colonies on chromogenic X-gal agar plates, indicating that the 272bp fragment does contain an active yeast promoter.
Quantitative determinations of promoter activity were made by colorimetric assay of ss-galactosidase activity in permeabilised cells which had been cultured for 3 days at 240C in selective minimal medium. The $-glucosidase fragment directed the synthesis of appreciable levels of
-galactosidase activity in S.cerevisiae AH22 transformants and the enzyme levels were comparable to those produced by the action of the S.cerevisiae alcohol dehydrogenase (ADCl) promoter@ promoter (Table 1). The ADC1 promoter fragment was derived from the yeast expression vector pAH9 (Ammerer, G., Methods in Enzymol., 101, (1983) 192-201) and contains 1.5Kb of 5' non-coding sequence in addition to the first three amino acids of the alcohol dehydrogenase gene on a Bam HI - Hind III fragment.This fragment was
inserted into the Bam HI - Hind III cloning sites of YEp 365 to give pTAG 3. No ss-galactosidase activity was detected in yeast cells transformed with the vector plasmid alone.
The results obtained are shown in Table 1 below:
TABLE 1
Assessment of C, tsukubaensis α-alucosidase promoter strenoth
Recombinant Promoter Vector B-galactosidase actiyity plasmid in fragment (units/O.D.600nm ml
S.cer. AH22 /min) pG8904 a-glu (272bp YEp 365 77.4
BamH1-Xhol) pTAG3 ADCl (1.5Kb YEp 365 73.5
BamH1-Hind111) TABLE 2
SUBSTRATE SPECIFICITIES OF CLONED ENZYME ENCODED BY
S. cerevisiae AH22 (pGA8701)
Substrate (2% w/v in Relative Sugar Linkage Type Sugar Unit Number
McILvaine buffer, pH 5.4) Activity
(%)
Maltose 100 α(1-4) 2
Maltotriose 59 α(1-4) 3
Maltotetraose 48 α(1-4) 4
Sucrose 55 Fructosyl-α-D-glucoside α-(1-2) 2
Panose 55 α(1-4), α(1-6) 3
Isomaltose 35 α(1-6) 2
Phenyl α-D-glucoside 18 Aryl-A*-D-glucoside 1
Melezitose 8.8 α(1-2) α;(1-3) 3
Amylose 7.5 α1-4) Polymer
Dextrin (Difco) 8.0 α(1-4), α(1-6) Polymer
Dextrin (B.D.H.) 6.8 α(1-4), α(1-6) Polymer
Dextrin (Puriss) 6.4 α(1-4), α(1-6) Polymer
Turanose 4.1 α(1-3) 2
Glycogen 0.95 α(1-4), α(1-6), Polymer α-methyl-D-Glucoside 0.7 AlkylFα-glucoside 1
Starch (lintners) 0.5 α(1-4), α(1-6) Polymer
Starch (Potato) 0 α(1-4), α(1-6) Polymer
Starch (corn) 0 α(1-4), α(1-6) Polymer
Amylopectin 0 α(1-6) Polymer
Pullulan 0 α(1-6) Polymer
Trehalose 0 Glucopuranoside 2 α-cyclodextrin 0 Cyclic dextrin Polymer TABLE 3
EFFECT OF Ph ON α;-GLUCOSIDASE ACTIVITY pH
3.4 3.9 4.2 4.4 4.6 4.9 5.4
Enzyme 5.53 6.96 7.17 7.26 6.97 6.67 5.03
Activity (units/ml) % Relative 75.95 96.11 99.40 100.00 96.10 92.0 69.38
Activity TABLE 4
EFFECT OF TEMPERATURE ON α-GLUCOSIDASE ACTIVITY
INCUBATION TEMPERATURE ( C)
20 40 45 50 55 58 60 6.5
Enzyme activity 1.1 3.1 3.7 4.5 5.5 5.7 5.6 2.3 (units/m)
Relative activity 19.3 53.5 64.0 79.0 96.5 100.0 99.1 40.4 (%) TABLE 5..
THEMOSTABILITY OF THE CLONED a-GLUCOSIDASE AT 60 C
PREINCUBATION TIME (MIN) AT 600C
0 1 2 5 10 20 60
Enzyme Activity 5.39 3.58 0.98 0 0 0 0 (units/ml)
Relative
Activity (%) 100 66.42 17.63 0 0 0 0
Table 6
Parent C.tsukubaensis Restriction M13 plasmid plasmid restriction enzymes used derivative
fragment to excise
fragments for
cloning into
M13 mpl8/mpl9
rf DNA pTSOOl Sall-Sall Sall pSS1901 pTS003 BamHl-Sall Hindlll+BamHl pHB1803
pHB1903 pTS004 BamHl-Xhol Hindlll+BamHl pHB1804
pHB1904 pTS005 Sall-Sall Sall pSS1905 pTS007 Sall-Hindlll Hindlll+BamHl pHB1807
pHB1907 pTS009 Hindlll-BamHl Hind111+BamH1 pHB1809
pHB1909 pTS010 Sal1-Hind111 Hind111+BamH1 pHB1810
pHB1910 pTSOll Pstl-Sall EcoRl+Pstl pEP1811 pEPl9 11 pTSO13 Xhol-Pstl EcoRl+Pstl pEP1813 pEP1913 pTSO14 Hind111-Ndel Hind111+BamH1 pHB1814
pHB1914 pTSOl5 Ndel-BamHl BamHl pBB1815
The recombinant bacteriophage M13 based mpl8 and mpl9 plasmid derivatives (column 4) were constructed by excising the restriction fragments (column 2) from the parent pUC8 recombinant plasmids (column 1) with the specific restriction endonucleases (column 3) and then cloned into homologous sites within the mpl8 and mpl9 rf DNA.
Claims (6)
1. Saccharomyces cerevisiae having an α-glucosidase gene from Candida tsukubaensis CBS 6389.
2. A method of providing Saccharomyces cerevisiae with enhanced g-glucosidolytic activity comprising transforming said Saccharomyces cerevisiae with an i-glucosidase gene from a genomic library prepared from Candida tsukubaensis.
3. A method of fermenting carbohydrate material comprising adding a culture of S.cerevisiae to an aqueous solution, suspension or dispersion of said carbohydrate material wherein S.cerevisiae has an i-glucosidase gene derived from
Candida tsukubaensis CBS 6389
4. A 4.39 Kb Bam Hl@ fragment having the nucleotide sequence set out in Fig. 5 of the accompanying Drawings.
5. A Bam Hl-Xhol fragment extending from nucleotide 1-272 of the above-identified 4.39 Kb Bam H1 fragment.
6. α-glucosidase obtained in an extracellular fraction of a culture of S.cerevisiae according to Claim 1.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9018268A GB2247238A (en) | 1990-08-20 | 1990-08-20 | Alpha-glucosidase gene from Candida tsukubaensis cloned and expressed in Saccharomyces cerevisiae |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9018268A GB2247238A (en) | 1990-08-20 | 1990-08-20 | Alpha-glucosidase gene from Candida tsukubaensis cloned and expressed in Saccharomyces cerevisiae |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| GB9018268D0 GB9018268D0 (en) | 1990-10-03 |
| GB2247238A true GB2247238A (en) | 1992-02-26 |
Family
ID=10680954
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB9018268A Withdrawn GB2247238A (en) | 1990-08-20 | 1990-08-20 | Alpha-glucosidase gene from Candida tsukubaensis cloned and expressed in Saccharomyces cerevisiae |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB2247238A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997024448A1 (en) * | 1995-12-28 | 1997-07-10 | Nickerson Biocem Limited | Potato alpha-glucosidase gene |
| GB2331300A (en) * | 1997-11-17 | 1999-05-19 | Danisco | Yeast expressing extracellular maltase |
| WO2002055652A1 (en) * | 2001-01-05 | 2002-07-18 | Amano Enzyme Inc. | Process for producing fermented malt drink |
| CN101085951B (en) * | 2001-01-05 | 2012-01-11 | 天野酶株式会社 | Method of manufacturing beer |
-
1990
- 1990-08-20 GB GB9018268A patent/GB2247238A/en not_active Withdrawn
Non-Patent Citations (1)
| Title |
|---|
| ANTONIE VAN LEEUWENHOEK,VOL 51,NO.3,1985,PAGES 275-287 * |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997024448A1 (en) * | 1995-12-28 | 1997-07-10 | Nickerson Biocem Limited | Potato alpha-glucosidase gene |
| GB2331300A (en) * | 1997-11-17 | 1999-05-19 | Danisco | Yeast expressing extracellular maltase |
| WO2002055652A1 (en) * | 2001-01-05 | 2002-07-18 | Amano Enzyme Inc. | Process for producing fermented malt drink |
| US7115289B2 (en) | 2001-01-05 | 2006-10-03 | Amano Enzyme Inc. | Method of manufacturing fermented malt beverages |
| CN100335606C (en) * | 2001-01-05 | 2007-09-05 | 天野酶株式会社 | Method for producing fermented malt beverage |
| CN101085951B (en) * | 2001-01-05 | 2012-01-11 | 天野酶株式会社 | Method of manufacturing beer |
Also Published As
| Publication number | Publication date |
|---|---|
| GB9018268D0 (en) | 1990-10-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2152217T5 (en) | XILANASE PRODUCTION. | |
| Søgaard et al. | Expression of cDNAs encoding barley α-amylase 1 and 2 in yeast and characterization of the secreted proteins | |
| CA1339101C (en) | Production of guar alpha-galactosidase and immunologically related alpha-galactosidases by host organisms transformed with recombinant dna methods | |
| JP3643404B2 (en) | Genes that confer aggregation to yeast and gene products thereof | |
| Suihko et al. | Recombinant brewer's yeast strains suitable for accelerated brewing | |
| US5028533A (en) | Precursor polypeptide, DNA sequence coding therefor, vectors host organisms, and processes involving same | |
| González-Candelas et al. | Construction of a recombinant wine yeast strain expressing a fungal pectate lyase gene | |
| Dohmen et al. | Regulated overproduction of α-amylase by transformation of the amylolytic yeast Schwanniomyces occidentalis | |
| CA1340101C (en) | Amylolytic enzymes producing microorganisms, constructed by recombinant dna technology and their use for fermentation processes | |
| Børsting et al. | Saccharomyces carlsbergensis contains two functional genes encoding the Acyl‐CoA binding protein, one similar to the ACB1 gene from S. cerevisiae and one identical to the ACB1 gene from S. monacensis | |
| San Segundo et al. | SSG1, a gene encoding a sporulation-specific 1, 3-beta-glucanase in Saccharomyces cerevisiae | |
| US6610514B2 (en) | Yeast vector and method of producing proteins using the same | |
| DK175566B1 (en) | DNA strand encoding alpha-acetolactate decarboxylase, yeast fungus transformed with the DNA strand, method of producing a yeast fungus with alpha-acetolactate-producing ability and method of preparation ..... | |
| US5100794A (en) | Amylolytic enzymes producing microorganisms, constructed by recombinant DNA technology and their use for permentation processes | |
| RU2235127C2 (en) | Method for transformation of yeast candida utilis, yeast strain candida utilis (variants), recombinant dna material for transformation of yeast strain candida utilis, gene his3 encoding dna sequence in indicated yeast | |
| JP3009679B2 (en) | Pectin lyase expression system | |
| JP2001025393A (en) | Aspergillus expression system | |
| Hilkka et al. | Cloning, sequence and chromosomal location of a MEL gene from Saccharomyces carlsbergensis NCYC396 | |
| GB2247238A (en) | Alpha-glucosidase gene from Candida tsukubaensis cloned and expressed in Saccharomyces cerevisiae | |
| US5055401A (en) | Construction of new α-galactosidase producing yeast strains and the industrial application of these strains | |
| US5151354A (en) | Fermentation processes using amylolytic enzyme producing microorganisms | |
| Southgate et al. | Expression and secretion of Bacillus amyloliquefaciens alpha-amylase by using the yeast pheromone alpha-factor promoter and leader sequence in Saccharomyces cerevisiae | |
| US5108925A (en) | Process for accelerated beer production by integrative expression in the PGK1 or ADC1 genes | |
| FI89724C (en) | FOERFARANDE FOER FRAMSTAELLNING AV -GALACTOSIDAS PRODUCERANDE JAESTSTAMMAR, -GALACTOSIDAS PRODUCERANDE JAESTSTAM OCH INDUSTRIELLA UTNYTTJINGSMETODER AV SAODANA JAESTSTAMMAR | |
| Laing et al. | A note on the primary structure and expression of an Erwinia carotovora polygalacturonase‐encoding gene (peh1) in Escherichia coli and Saccharomyces cerevisiae |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |